As a partner, Dawn Norman’s expertise and leadership have helped propel MRC Global’s continued growth as a leading regulatory and compliance consulting firm highly respected throughout the medical device industry. With an extensive background in the medical device and biologics industry that includes VC-funded startups to Fortune 100 device manufacturers, Norman’s depth of experience allows her to develop custom client solutions, go-to strategies for clinical studies and evaluations, and a risk-based approach related to regulatory and quality systems. Before MRC Global, Norman spent 15 years in the medical device industry working with venture capital-backed startups and larger companies alike. She focused on regulatory strategy and submissions, along with clinical study design and study execution. Norman was directly involved with early development and market entry for leading-edge medical innovation including novel diagnostic and therapeutic devices for neurosurgical, neurological, neurovascular and cardiac indications, cardiac ablation, recombinant proteins and growth factors for bone fusion and soft tissue regeneration, orthopedic trauma, infusion pumps, artificial intelligence and machine leaning devices for assistive diagnostic indications, dental, female and reproductive health, and advanced robotic and imaging technologies.